These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21993076)

  • 1. Antibody response in MOG(35-55) induced EAE.
    Lalive PH; Molnarfi N; Benkhoucha M; Weber MS; Santiago-Raber ML
    J Neuroimmunol; 2011 Dec; 240-241():28-33. PubMed ID: 21993076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
    Ford ML; Evavold BD
    Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis.
    Sekiguchi Y; Ichikawa M; Takamoto M; Ota H; Koh CS; Muramatsu M; Honjo T; Agematsu K
    Immunol Lett; 2009 Feb; 122(2):145-9. PubMed ID: 18824198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
    Oliver AR; Lyon GM; Ruddle NH
    J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells.
    Kap YS; Smith P; Jagessar SA; Remarque E; Blezer E; Strijkers GJ; Laman JD; Hintzen RQ; Bauer J; Brok HP; 't Hart BA
    J Immunol; 2008 Feb; 180(3):1326-37. PubMed ID: 18209026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
    Mendel I; Natarajan K; Ben-Nun A; Shevach EM
    J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.
    Vollmer TL; Liu R; Price M; Rhodes S; La Cava A; Shi FD
    J Immunol; 2005 Mar; 174(5):2696-701. PubMed ID: 15728477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
    Furlan R; Kurne A; Bergami A; Brambilla E; Maucci R; Gasparini L; Butti E; Comi G; Ongini E; Martino G
    J Neuroimmunol; 2004 May; 150(1-2):10-9. PubMed ID: 15081244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis.
    Gur H; Mendel I; Kerlero de Rosbo N; Ben-Nun A
    J Autoimmun; 1999 Aug; 13(1):3-10. PubMed ID: 10441162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
    Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
    J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
    Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
    Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.